|
References
1. CDC Division of Bacterial and Mycotic Diseases. Group A Streptococcal (GAS) Disease, Technical Information. Oct 11, 2005. Available at www.cdc.gov/ncidod. Last accessed Aug. 1, 2006.
2. Stevens DL. The independent evolution of healthcare-associated and community-acquired MRSA. Presentation from symposium: "Evaluating Strategies to Improve Patient Outcomes: Community-Acquired and Nosocomial MRSA" held at the San Francisco Marriott, San Francisco, CA. Oct. 18, 2005. Available at: www.medscape.com/viewprogram/4951. Last accessed Aug. 1, 2006.
3. Stevens DL. Streptococcal-toxic shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infectious Diseases, July-September 1995;1(3):69-78.
4. Trent JT, Kirsner RS. Necrotizing fasciitis. Wounds 14(8):284-292, 2002. 2002 Health Management Publications, Inc. Available at: http://www.medscape.com/viewarticle/444061. Last accessed Aug. 1, 2006.
5. CDC. Outbreak of invasive Group A Streptococcus associated with varicella in a childcare center-Boston, Massachusetts, 1997. MMWR 1997, 46 (40); 944-948.
6. Bradley SF. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Seminar on Respiratory Critical Care Medicine 2005; 26(6):643-649. Available at: www.medscape.com/viewarticle/521338. Last accessed Aug. 1, 2006.
7. Chambers HF. MRSA: the San Francisco experience; program and abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy December 16-19, 2005 Washington, DC, Abstract 1324.
8. Chambers HF. Gram positive cocci: community-acquired MRSA: epidemiology and treatment. Program and abstracts of the Infectious Diseases Society of America 2004 Annual Meeting; September 30-October 3, 2004; Boston, Massachusetts, Abstract 772.
9. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11(6) June 2005. Available at www.cdc.gov/eid. Last accessed Aug. 1, 2006.
10. Bulger EM. Treating severe soft tissue infections: how and what I do; presentation from the 25th Annual Surgical Infection Society Meeting. May 5, 2005.
11. Clegg HW, Dallas SD, Roddey OF, et al. Extra-pharyngeal group A streptococcus infection: diagnostic accuracy and utility of rapid antigen testing. Pediatric Infectious Disease Journal, 2003;22(8):726-731. Available at: http://www.medscape.com/viewarticle/460806. Last accessed Aug. 1, 2006.
12. Ruoff KL, Whiley RA and Beighton D. Streptococcus. In: Murray PR. Baron EJ, Pfaller MA, et al., eds. Manual of Clinical Microbiology. Volume 2, 8th ed. Washington, DC: American Society for Microbiology Press; 2003:405-419.
13. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16. Wayne, PA 2006.
14. Bannerman, TL. Staphylococcus, micrococcus, and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Pfaller MA, et al., eds. Manual of Clincal Microbiology. Volume 2, 8th ed. Washington, DC: American Society for Microbiology Press; 2003:384-399.
15. Ginocchio CC. Methods for the detection of MRSA, presentation by director of Microbiology/Virology and Molecular Diagnostics, North Shore-LIJ Health System Laboratories, NY Allied Professional, North Shore University Hospital-New York University School of Medicine, NY 2005.
16. Sabharwal H, Michon F, Nelson D, et al. Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection. J Infect Dis 2006;193(1):129-135.
17. Miller LG,Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med, 2005;352:1445-53.
18. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444.
19. Waknine Y. MRSA outbreak prompts change in prescribing habits. From: Purcell K presentation at the 15th annual Society for Healthcare Epidemiology of America (SHEA) meeting, April 11, 2005, Abstract 210.
20. Waknine Y. Community-acquired MRSA skin/soft tissue infection rates increasing. From: Andrabi S. presentation at the 15th annual Society for Healthcare Epidemiology of America (SHEA). April 11, 2005, Abstract 173.
21. Bootsma, MC, Diekman O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: quantifyng the effects of interventions and rapid diagnostic testing. Proceedings of the National Academy of Sciences USA 2006;103(14):5620-5625.
22. CDC and the department of Health and Human Services. Strategies for clinical management of MRSA in the community: summary of and experts' meeting convened by the Centers for Disease Control and Prevention. Summary of July, 2004 meeting and data available January 2006.
23. Goossens, H. Antibiotic resistance: highlights of the 16th European Congress on Clinical Microbiology and Infectious Diseases. Nice, France, April 1-4, 2006.
|